Si-Bone Inc
SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFu… Read more
Si-Bone Inc (SIBN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.014x
Based on the latest financial reports, Si-Bone Inc (SIBN) has a cash flow conversion efficiency ratio of 0.014x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.33 Million) by net assets ($172.13 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Si-Bone Inc - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Si-Bone Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Si-Bone Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Si-Bone Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MedCap AB (publ)
ST:MCAP
|
0.104x |
|
MorningStar Partners, L.P.
NYSE:TXO
|
0.038x |
|
Jiangxi Ganneng Co Ltd
SHE:000899
|
0.125x |
|
Pell Bio-Med Technology Co., Ltd.
TW:6949
|
-0.061x |
|
CGN Nuclear Technology Development Co Ltd
SHE:000881
|
0.016x |
|
Senton Energy Co. Ltd. A
SHE:001331
|
N/A |
|
Kunshan Guoli Electronic Technology Co Ltd
SHG:688103
|
0.012x |
|
Ur Energy Inc
NYSE MKT:URG
|
-0.166x |
Annual Cash Flow Conversion Efficiency for Si-Bone Inc (2013–2024)
The table below shows the annual cash flow conversion efficiency of Si-Bone Inc from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $166.96 Million | $-12.43 Million | -0.074x | +32.64% |
| 2023-12-31 | $169.38 Million | $-18.71 Million | -0.110x | +73.93% |
| 2022-12-31 | $98.30 Million | $-41.66 Million | -0.424x | -44.08% |
| 2021-12-31 | $134.42 Million | $-39.53 Million | -0.294x | -62.45% |
| 2020-12-31 | $169.36 Million | $-30.66 Million | -0.181x | +63.93% |
| 2019-12-31 | $63.01 Million | $-31.63 Million | -0.502x | -211.81% |
| 2018-12-31 | $90.19 Million | $-14.52 Million | -0.161x | -218.81% |
| 2017-12-31 | $-129.38 Million | $-17.53 Million | 0.135x | -12.06% |
| 2016-12-31 | $-108.73 Million | $-16.75 Million | 0.154x | +101.86% |
| 2015-12-31 | $3.23 Million | $-26.72 Million | -8.264x | -116.34% |
| 2014-12-31 | $6.89 Million | $-26.33 Million | -3.820x | -1215.61% |
| 2013-12-31 | $-1.65 Million | $-566.00K | 0.342x | -- |